Molecular analysis of NTB-A signaling: A role for EAT-2 in NTB-A-mediated activation of human NK cells

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 3170-3177

  Eissmann, Philipp ^a,b   Watzl, Carsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CELL RECEPTOR; CYTOKINE; GAMMA INTERFERON; MUTANT PROTEIN; PROTEIN EAT 2; PROTEIN NTB A; PROTEIN TYROSINE KINASE; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; CYTOTOXICITY; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 33747760033     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.3170     Document Type: Article

References (39)

1. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1: 41-49.
2. Long, E. O. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17: 875-904.
3. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
4. Veillette, A., and S. Latour. 2003. The SLAM family of immune-cell receptors. Curr. Opin. Immunol. 15: 277-285.
5. Bhat, R., P. Eissmann, J. Endt, S. Hoffmann, and C. Watzl. 2006. Fine-tuning of immune responses by SLAM-related receptors. J. Leukocyte Biol. 79: 417-424.
6. Shlapatska, L. M., S. V. Mikhalap, A. G. Berdova, O. M. Zelensky, T. J. Yun, K. E. Nichols, E. A. Clark, and S. P. Sidorenko. 2001. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J. Immunol. 166: 5480-5487.
7. Morra, M., D. Howie, M. S. Grande, J. Sayos, N. Wang, C. Wu, P. Engel, and C. Terhorst. 2001. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu. Rev. Immunol. 19: 657-682.
8. Latour, S., and A. Veillette. 2003. Molecular and immunological basis of X-linked lymphoproliferative disease. Immunol. Rev. 192: 212-224.
9. Chan, B., A. Lanyi, H. K. Song, J. Griesbach, M. Simarro-Grande, F. Poy, D. Howie, J. Sumegi, C. Terhorst, and M. J. Eck. 2003. SAP couples Fyn to SLAM immune receptors. Nat. Cell Biol. 5: 155-160.
10. Latour, S., R. Roncagalli, R. Chen, M. Bakinowski, X. Shi, P. L. Schwartzberg, D. Davidson, and A. Veillette. 2003. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nat. Cell Biol. 5: 149-154.
11. Tangye, S. G., S. Lazetic, E. Woollatt, G. R. Sutherland, L. L. Lanier, and J. H. Phillips. 1999. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 162: 6981-6985.
12. Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M. G. Roncarolo, et al. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395: 462-469.
13. Eissmann, P., L. Beauchamp, J. Wooters, J. C. Tilton, E. O. Long, and C. Watzl. 2005. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105: 4722-4729.
14. Thompson, A. D., B. S. Braun, A. Arvand, S. D. Stewart, W. A. May, E. Chen, J. Korenberg, and C. Denny. 1996. EAT-2 is a novel SH2 domain containing protein that is up-regulated by Ewing's sarcoma EWS/FLI1 fusion gene. Oncogene 13: 2649-2658.
15. Morra, M., J. Lu, F. Poy, M. Martin, J. Sayos, S. Calpe, C. Gullo, D. Howie, S. Rietdijk, A. Thompson, et al. 2001. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. EMBO J. 20: 5840-5852.
16. Roncagalli, R., J. E. Taylor, S. Zhang, X. Shi, R. Chen, M. E. Cruz-Munoz, L. Yin, S. Latour, and A. Veillette. 2005. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nat. Immunol. 6: 1002-1010.
17. Tassi, I., and M. Colonna. 2005. The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and activates the PI3K and phospholipase Cy signaling pathways in human NK cells. J. Immunol. 175: 7996-8002.
18. Bottino, C., M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L. D. Notarangelo, L. Moretta, and A. Moretta. 2001. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194: 235-246.
19. Fraser, C. C., D. Howie, M. Morra, Y. Qiu, C. Murphy, Q. Shen, J. C. Gutierrez-Ramos, A. Coyle, G. A. Kingsbury, and C. Terhorst. 2002. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family. Immunogenetics 53: 843-850.
20. Munitz, A., I. Bachelet, S. Fraenkel, G. Katz, O. Mandelboim, H. U. Simon, L. Moretta, M. Colonna, and F. Levi-Schaffer. 2005. 2B4 (CD244) is expressed and functional on human eosinophils. J. Immunol. 174: 110-118.
21. Flaig, R. M., S. Stark, and C. Watzl. 2004. Cutting edge: NTB-A activates NK cells via homophilic interaction. J. Immunol. 172: 6524-6527.
22. Falco, M., E. Marcenaro, E. Romeo, F. Bellora, D. Marras, F. Vely, G. Ferracci, L. Moretta, A. Moretta, and C. Bottino. 2004. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur. J. Immunol. 34: 1663-1672.
23. Valdez, P. A., H. Wang, D. Seshasayee, M. van Lookeren Campagneqq, A. Gurney, W. P. Lee, and I. S. Grewal. 2004. NTB-A, a new activating receptor in T cells that regulates autoimmune disease. J. Biol. Chem. 279: 8662-18669.
24. Howie, D., F. S. Laroux, M. Morra, A. R. Satoskar, L. E. Rosas, W. A. Faubion, A. Julien, S. Rietdijk, A. J. Coyle, C. Fraser, and C. Terhorst. 2005. Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functions. J. Immunol. 174: 5931-5935.
25. Stark, S., and C. Watzl. 2006. 2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells. Int. Immunol. 18: 241-247.
26. Watzl, C., C. C. Stebbins, and E. O. Long. 2000. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165: 3545-3548.
27. Watzl, C., and E. O. Long. 2003. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med. 197: 77-85.
28. Leibson, P. J. 1997. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6: 655-661.
29. Jiang, K., B. Zhong, D. L. Gilvary, B. C. Corliss, E. Hong-Geller, S. Wei, and J. Y. Djeu. 2000. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1: 419-425.
30. Chen, R., F. Relouzat, R. Roncagalli, A. Aoukaty, R. Tan, S. Latour, and A. Veillette. 2004. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors. Mol. Cell. Biol. 24: 5144-5156.
31. Chuang, S. S., P. R. Kumaresan, and P. A. Mathew. 2001. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways. J. Immunol. 167: 6210-6216.
32. Aoukaty, A., and R. Tan. 2002. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. J. Biol. Chem. 277: 13331-13337.
33. Aoukaty, A., and R. Tan. 2005. Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease. J. Immunol. 174: 4551-4558.
34. Kiel, M. J., O. H. Yilmaz, T. Iwashita, O. H. Yilmaz, C. Terhorst, and S. J. Morrison. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109-1121.
35. Sayos, J., M. Martin, A. Chen, M. Simarro, D. Howie, M. Morra, P. Engel, and C. Terhorst. 2001. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. Blood 97: 3867-3874.
36. Tangye, S. G., K. E. Nichols, N. J. Hare, and B. C. van de Weerdt. 2003. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation. J. Immunol. 171: 2485-2495.
37. Nanda, N., P. Andre, M. Bao, K. Clauser, F. Deguzman, D. Howie, P. B. Conley, C. Terhorst, and D. R. Phillips. 2005. Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling. Blood 106: 3028-3034.
38. Latour, S., G. Gish, C. D. Helgason, R. K. Humphries, T. Pawson, and A. Veillette. 2001. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat. Immunol. 2: 681-690.
39. Bouchon, A., M. Cella, H. L. Grierson, J. I. Cohen, and M. Colonna. 2001. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J. Immunol. 167: 5517-5521.